Christopher Stephen Towler

Title: Christopher Stephen Towler: Innovator in Ocular Treatments

Introduction

Christopher Stephen Towler is a notable inventor based in Quincy, MA (US). He has made significant contributions to the field of ocular treatments, particularly through his innovative patent. His work focuses on improving the quality of life for individuals suffering from ocular surface pain and related conditions.

Latest Patents

Towler holds a patent for "Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and formulations thereof." This patent provides polymorphs and formulations of the compound, which is aimed at treating ocular surface pain. The invention also includes methods for addressing dry eye disease and ocular hyperemia through the administration of this compound.

Career Highlights

Towler is associated with Bausch + Lomb Ireland Limited, a company renowned for its commitment to eye health and innovative solutions. His work at the company has positioned him as a key player in the development of new treatments for ocular conditions.

Collaborations

Towler has collaborated with notable colleagues, including Joseph Paul Bullock and Chinmay Maheshwari. These partnerships have contributed to the advancement of research and development in the field of ocular health.

Conclusion

Christopher Stephen Towler's contributions to ocular treatments through his patent and work at Bausch + Lomb Ireland Limited highlight his dedication to improving patient care. His innovative approaches continue to pave the way for advancements in the treatment of eye-related ailments.